Activin and Inhibin

FT895 is a potent and selective HDAC11 inhibitor with an IC 50 of 3 nMIn VitroFT895 is a highly selective HDAC11 inhibitor showing greater than 1000-fold selectivity against the other 10 members of the HDAC family. MCE has not independently

FT895 is a potent and selective HDAC11 inhibitor with an IC 50 of 3 nMIn VitroFT895 is a highly selective HDAC11 inhibitor showing greater than 1000-fold selectivity against the other 10 members of the HDAC family. MCE has not independently

FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&amp: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).

FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&amp: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).

FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&amp: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).

FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyForm:SolidIC50&amp: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).

FTI-276 is a protein farnesyl transferase (PFT) inhibitor with IC 50 s of 0.9 nM and 0.5 nM for Plasmodium falciparum and human, respectivelyIC50&amp: Target:IC50: 0.9 nM (PFT, Plasmodium falciparum ), 0.5 nM (PFT, human).

FTI-2153 is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer activity.In VitroFTI-2153,

FTI-2153 is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer activity.In VitroFTI-2153,

FTI-2153 is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer activity.In VitroFTI-2153,

FTI-2153 is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer activity.In VitroFTI-2153,

FTI-2153 is a potent and highly selective inhibitor of farnesyltransferase (FTase) , with an IC 50 of 1.4 nM. FTI-2153 is &gt:3000-fold more potent at blocking H-Ras ( IC 50 , 10 nM) than Rap1A processing. Anti-cancer activity.In VitroFTI-2153,